All News
Can "Ultra-low" dose Rituximab work for RA?
The REDO trial presented data in abstract 1443 in an oral presentation challenging how low we can go with rituximab for rheumatoid arthritis. Their study randomized 118 patients with rheumatoid arthritis to 1000 mg, 500 mg, and "ultra-low" dose 200 mg.
Read Article
RA: Cardiovascular Risk Stratification and Potential Predictors of Risk
Early cardiovascular disease assessment and management is critical at diagnosis in patients with Rheumatoid Arthritis (RA).
Read Article
Tired of Doing Nothing About Fatigue: Dr. David Liew ( @drdavidliew ) discusses abstract #0462 presented at the #ACR21 annual meeting.
https://t.co/jEUVNNAVsL https://t.co/uwSymr8xuh
Links:
Dr. John Cush RheumNow ( View Tweet)
The Need for Comparative Treatment Trials in Psoriatic Arthritis
Dr. Richard Conway ( @RichardPAConway) discusses a small sample of novel agents demonstrating efficacy in PsA presented at #ACR21, we have Abs #453, Abs #488, and Abstract #490.
https://t.co/eXBN1XFhRl https://t.co/McxpwTse16
Links:
Dr. John Cush RheumNow ( View Tweet)
Treating RA: Does Where You Live Matter? Dr. Mrinalini Dey ( @DrMiniDey ) discusses abstract #0494 presented at the #ACR21 annual meeting.
https://t.co/xqKSPKelCQ https://t.co/Q6UKuExnwV
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of Spondyloarthritis from Day 1: Dr. Robert Chao ( @doctorRBC) reviews some of the best abstracts he saw on day 1 (Saturday) presented at the #ACR21 annual meeting, including abstracts #0068 and #0062.
https://t.co/qzPiXqzOWe https://t.co/6LX5iPtcJR
Links:
Dr. John Cush RheumNow ( View Tweet)
New Insights into Uveitis in Spondyloarthritis
There have been some updates on uveitis in SpA at #ACR21 shared by Dr. Antoni Chan ( @synovialjoints).
https://t.co/cl2CvWzTcv https://t.co/v4FltWUEH6
Links:
Dr. John Cush RheumNow ( View Tweet)
#ACR21 Best Abstracts We Saw - Day 3 (Monday)
The third day of ACR 2021 took a big leap in online content. We share compilation (with links) of presentations were the “ACRBest” as seen by our RheumNow faculty.
https://t.co/kQlLZwBDH6 https://t.co/rkVhpbLkwR
Links:
Dr. John Cush RheumNow ( View Tweet)
Recognizing and Treating Axial Disease in Psoriatic Arthritis: Dr. Pedro Castillo ( @_Castillo_Pedro) reviews highlights from an #ACR21 session, Session 6S403, presented at the ACR21 annual meeting.
https://t.co/9FOfmAI8Gs https://t.co/kiLesu72yI
Links:
Dr. John Cush RheumNow ( View Tweet)
For those of you playing along at home - the @RheumNow GCA/PMR panel's highlights #ACR21:
bari in GCA: https://t.co/QZhzQEt8GE
secukinumab in GCA:
https://t.co/OJQDBR5Hyy
8w PNL w TCZ in GCA:
https://t.co/ejnsVYeSgo
TCZ for PMR:
https://t.co/suWkQ5CgyP
Links:
- David Liew on Twitter: "Baricitinib for *relapsing* GCA (Th1+Th17) w a…
- David Liew on Twitter: "Secukinumab in GCA, phase 2 (TitAIN): I can…
- David Liew on Twitter: "How much PNL do you need with TCZ in GCA, to avoid…
- David Liew on Twitter: "It's all happening for biologic therapies in P…
David Liew drdavidliew ( View Tweet)
Burning question: How many nrAxSpA pts "progress" to AxSpA? Check out my video on abstract 0907 from #ACR21 #RheumNow
https://t.co/M78SrD25KP
Dr. Rachel Tate uptoTate ( View Tweet)
Day 2 Report from ACR21
Highlight reports from Sunday, Day 2 at #ACR21 Convergence
https://t.co/Zo6Vw8mAsI https://t.co/nqxSP9euV8
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Jack Cush, Dr. Aurelie Najam ( @AurelieRheumo) , Dr. Bella Mehta ( @bella_mehta) Dr. Yuz Yusof ( @Yuz6Yusof), Dr. Pedro Castillo ( @_Castillo_Pedro) and Dr. Richard Conway ( @RichardPAConway) discuss highlights from the first full day of the #ACR21.
https://t.co/eLrAzYvcMG https://t.co/c5gGfFK1KO
Links:
Dr. John Cush RheumNow ( View Tweet)
RA Risk in Cardiovascular Disease: Dr. Eric Dein ( @ericdeinmd ) discusses abstracts #0269 and #0271 presented at the #ACR21 annual meeting.
https://t.co/qSdfuqKbMI https://t.co/Lw1rGGF2Zt
Links:
Dr. John Cush RheumNow ( View Tweet)
Does RA Begin in the Gut? Dr. Jonathan Kay reviews abstract #0461 presented at the #ACR21 annual meeting.
https://t.co/Q2WrJ8XYUZ https://t.co/jLaczx9ya4
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
Lupus Updates with Dr. Michelle Petri
https://t.co/4YZt4Pko4z https://t.co/MaXV5EXEVv
Links:
Dr. John Cush RheumNow ( View Tweet)
Infection or Disease Flare: What Tools Can Help Differentiate?
Dr. Olga Petryna ( @DrPetryna) shares studies presented at #ACR21.
https://t.co/EOwgjdCzUO https://t.co/bbwLfNq2cO
Links:
Dr. John Cush RheumNow ( View Tweet)
Evolution of Rheumatoid Arthritis: Arthur Kavanaugh
Dr. Arthur Kavanaugh reviews several RA-related studies presented at the #ACR21 annual meeting. https://t.co/LdeMH1k362
Dr. John Cush RheumNow ( View Tweet)
Which achievable Target could reduce mortality by just over 50% in #lupus 🦋? Do watch my video on Treat to Target in SLE: Dr. Yuzaiful Yusof https://t.co/H8kgFW9H06 via @YouTube @RheumNow
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)